These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 630748)

  • 1. Primary dysmenorrhea.
    Abraham GE
    Clin Obstet Gynecol; 1978 Mar; 21(1):139-45. PubMed ID: 630748
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium antagonists and dysmenorrhea.
    Andersson KE
    Ann N Y Acad Sci; 1988; 522():747-56. PubMed ID: 3288067
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of primary dysmenorrhea with prostaglandin synthetase inhibitors].
    Lundström V
    Lakartidningen; 1979 Feb; 76(8):614-6. PubMed ID: 105214
    [No Abstract]   [Full Text] [Related]  

  • 4. A rationale for the treatment of dysmenorrhea.
    Csapo AI
    J Reprod Med; 1980 Oct; 25(4 Suppl):213-21. PubMed ID: 7001020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of the etiology and management of dysmenorrhea in adolescence.
    Alvin PE; Litt IF
    Pediatrics; 1982 Oct; 70(4):516-25. PubMed ID: 6812011
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostaglandins, prostaglandin inhibitors and their roles in gynaecological disorders.
    Fraser IS
    Baillieres Clin Obstet Gynaecol; 1992 Dec; 6(4):829-57. PubMed ID: 1478000
    [No Abstract]   [Full Text] [Related]  

  • 7. Suppression of uterine activity by prostaglandin synthetase inhibitors.
    Pulkkinen MO
    Acta Obstet Gynecol Scand Suppl; 1979; 87():39-43. PubMed ID: 111465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a vasopressin antagonist in women with dysmenorrhea.
    Valentin L; Sladkevicius P; Kindahl H; Broeders A; Marsal K; Melin P
    Gynecol Obstet Invest; 2000; 50(3):170-7. PubMed ID: 11014949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracts of compound Muniziqi granule suppressed uterus contraction and ameliorated oxytocin-induced primary dysmenorrhea.
    Wei Y; Ma T; Wang H; Xing J; Wang Y; Gu Z; Mu D; Yin Q; Cheng X; Wang C
    J Ethnopharmacol; 2018 Sep; 223():33-40. PubMed ID: 29783015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Traditional Chinese medicine Guizhi Fuling capsule used for therapy of dysmenorrhea via attenuating uterus contraction.
    Sun L; Liu L; Zong S; Wang Z; Zhou J; Xu Z; Ding G; Xiao W; Kou J
    J Ethnopharmacol; 2016 Sep; 191():273-279. PubMed ID: 27340106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary dysmenorrhea: pathogenesis and therapy.
    Kulig JW
    Conn Med; 1982 Mar; 46(3):123-5. PubMed ID: 7075181
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of endogenous prostaglandins inhibition on the activity of human non-pregnant uterus in vitro].
    Laudanski T; Rocki W
    Ginekol Pol; 1976 Aug; 47(8):895-900. PubMed ID: 971858
    [No Abstract]   [Full Text] [Related]  

  • 13. Dysmenorrhea and prostaglandins.
    Halbert DR; Demers LM; Darnell Jones DE
    Obstet Gynecol Surv; 1976 Jan; 31(1):77-81. PubMed ID: 1107903
    [No Abstract]   [Full Text] [Related]  

  • 14. Ge-Gen Decoction attenuates oxytocin-induced uterine contraction and writhing response: potential application in primary dysmenorrhea therapy.
    Yang L; Chai CZ; Yue XY; Yan Y; Kou JP; Cao ZY; Yu BY
    Chin J Nat Med; 2016 Feb; 14(2):124-132. PubMed ID: 26968678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of an oral contraceptive in primary dysmenorrhea--changes in uterine activity and reactivity to agonists.
    Ekström P; Juchnicka E; Laudanski T; Akerlund M
    Contraception; 1989 Jul; 40(1):39-47. PubMed ID: 2505970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of inhibitors of prostaglandin synthesis in primary dysmenorrhea studied with hysterometry.
    Joelsson I; Lalos O
    Acta Obstet Gynecol Scand Suppl; 1979; 87():45-49. PubMed ID: 380251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naproxen and naproxen sodium in dysmenorrhea: development from in vitro inhibition of prostaglandin synthesis to suppression of uterine contractions in women and demonstration of clinical efficacy.
    Henzl MR; Izu A
    Acta Obstet Gynecol Scand Suppl; 1979; 87():105-17. PubMed ID: 380249
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of an oral contraceptive on uterine tonicity in women with primary dysmenorrhea.
    Lalos O; Joelsson I
    Acta Obstet Gynecol Scand; 1981; 60(3):229-32. PubMed ID: 7270089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary dysmenorrhea: the therapeutic challenge.
    Henzl MR; Massey S; Hanson FW; Buttram VC; Rosenwaks Z; Pauls FD
    J Reprod Med; 1980 Oct; 25(4 Suppl):226-35. PubMed ID: 7001022
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial: a new line on dysmenorphea.
    Br Med J; 1975 May; 2(5969):461-2. PubMed ID: 1148658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.